Case report highlights multimodal treatment for chest wall recurrence in breast cancer, suggesting reevaluation of management approaches.
INTRODUCTION: Management of chest wall recurrence after mastectomy remains debated. While surgery is invasive, both Japanese and international guidelines allow resection in selected patients and complete excision can provide durable control. With advances in systemic therapy, the value of aggressive local treatment for isolated recurrence requires reevaluation. Tumor biology and changes in receptor status after prior therapy also affect prognosis. However, infectious ribs or cartilage ulcers following chemotherapy and chest wall reconstruction are rarely reported. We describe a case of chest wall recurrence treated with multimodal therapy, including resection and reconstruction, complicated by infectious costochondritis.
No takes yet. Share an insight, caveat, or question.
Katayama et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: